| Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity ACC Aguiar, E Murce, WA Cortopassi, AS Pimentel, MMFS Almeida, ... International Journal for Parasitology: Drugs and Drug Resistance 8 (3), 459-464, 2018 | 104 | 2018 |
| Prednisolone adsorption on lung surfactant models: insights on the formation of nanoaggregates, monolayer collapse and prednisolone spreading ED Estrada-López, E Murce, MPP Franca, AS Pimentel RSC advances 7 (9), 5272-5281, 2017 | 35 | 2017 |
| 3p-C-NETA: A versatile and effective chelator for development of Al18F-labeled and therapeutic radiopharmaceuticals S Ahenkorah, E Murce, C Cawthorne, JP Ketchemen, CM Deroose, ... Theranostics 12 (13), 5971, 2022 | 14 | 2022 |
| Structure-based de novo design, molecular docking and molecular dynamics of primaquine analogues acting as quinone reductase II inhibitors E Murce, TR Cuya-Guizado, HI Padilla-Chavarria, TCC França, ... Journal of Molecular Graphics and Modelling 62, 235-244, 2015 | 6 | 2015 |
| Preclinical Evaluation of a PSMA-Targeting Homodimer with an Optimized Linker for Imaging of Prostate Cancer E Murce, S Beekman, E Spaan, M Handula, D Stuurman, C de Ridder, ... Molecules 28 (10), 4022, 2023 | 3 | 2023 |
| Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer E Murce, E Spaan, S Beekman, L van den Brink, M Handula, D Stuurman, ... Pharmaceuticals 16 (8), 1072, 2023 | 1 | 2023 |
| Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers E Murce, E de Blois, S van den Berg, M de Jong, Y Seimbille Royal Society open science 10 (3), 220950, 2023 | 1 | 2023 |
| Direct comparison of [18F] AlF-NOTA-JR11 and [18F] AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist S Ahenkorah, C Cawthorne, E Murce, CM Deroose, T Cardinaels, ... Nuclear Medicine and Biology 118, 108338, 2023 | 1 | 2023 |
| Direct comparison of [18F] AlF-NOTA-JR11 and [18F] AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: antagonist versus agonist F Cleeren, S Ahenkorah, E Murce, C Cawthorne, C Deroose, ... Nuclear Medicine and Biology 126, 108641, 2023 | | 2023 |
| Preclinical evaluation of ePSMA-DM1: a PSMA-targeting theranostic small molecule drug conjugate Y Seimbille, E Murce, E Spaan, S Beekman, M Handula, C de Ridder, ... Nuclear Medicine and Biology 126, 108472, 2023 | | 2023 |
| 3p‑C‑NETA‑TATE: a theranostic somatostatin analogue targeting neuroendocrine tumors S Ahenkorah, E Murce, C Cawthorne, Y Seimbille, T Cardinaels, ... EJNMMI Radiopharmacy and Chemistry 8 (Suppl1), 2023 | | 2023 |
| Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics E Murce, S Ahenkorah, S Beekman, M Handula, D Stuurman, C de Ridder, ... Pharmaceuticals 16 (6), 882, 2023 | | 2023 |
| Radiochemical and preliminary biological comparison of a 3p-C-NETA-PSMA and a DOTA-GA-PSMA derivative E Murce, S Ahenkorah, S Beekman, B Lilian, S Dalm, F Cleeren, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (SUPPL 1), 425-425, 2022 | | 2022 |
| Development of PSMA-targeted vectors containing an albumin binder and a cleavable linker E Murce, S Ahenkorah, E de Blois, F Cleeren, M De Jong, Y Seimbille Nuclear Medicine And Biology 108, S48-S49, 2022 | | 2022 |
| 3p-C-NETA-TATE: a versatile somatostatin analogue for Al18F-labeled and therapeutic SSTR2 targeting radiopharmaceuticals S Ahenkorah, E Murce, JP Ketchemen, C Cawthorne, Y Seimbille, ... Nuclear Medicine And Biology 108, S10-S11, 2022 | | 2022 |
| Synthesis of a PSMA-targeting ligand with an optimized linker for imaging and treatment of prostate cancer E Murce, E Spaan, Y Seimbille Nuclear Medicine and Biology 108, S206-S207, 2022 | | 2022 |
| (AlF)-F-18-3p-C-NETA-TATE: Combining a versatile and highly effective chelator with an established somatostatin analogue S Ahenkorah, E Murce, Y Seimbille, T Cardinaels, C Deroose, G Bormans, ... European Journal Of Nuclear Medicine And Molecular Imaging 48 (SUPPL 1 …, 2021 | | 2021 |
| Molecular Docking, Molecular Dynamics, and In Silico Prediction of the Toxic Potential of Primaquine Thiazolidinone Derivatives E Murce, AS Pimentel Letters in Drug Design & Discovery 14 (3), 345-353, 2017 | | 2017 |
